Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Hyperinsulinism-Hyperammonemia Syndrome | R-HSA-2206302 | 0 | FAD | 145068 | smpdb |
| Malonyl-CoA Decarboxylase Deficiency | R-ALL-2046066 | 0 | FAD | 145068 | smpdb |
| Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome] | 0 | 0 | FAD | 145068 | smpdb |
| Folate Metabolism | R-HSA-196757 | 0 | FAD | 145068 | smpdb |
| AICA-Ribosiduria | R-ALL-111409 | 0 | FAD | 145068 | smpdb |
| 2-Aminoadipic 2-Oxoadipic Aciduria | R-ALL-113577 | 0 | FAD | 145068 | smpdb |
| Capecitabine Metabolism Pathway | R-HSA-1430728 | 0 | FAD | 145068 | smpdb |
| Porphyria Variegata | R-HSA-189439 | 0 | FAD | 145068 | smpdb |
| Hyperlysinemia I, Familial | R-HSA-6809602 | 0 | FAD | 145068 | smpdb |
| Threonine and 2-Oxobutanoate Degradation | R-HSA-8849175 | 0 | FAD | 145068 | smpdb |
| 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I | 0 | 0 | FAD | 145068 | smpdb |
| Pravastatin Action Pathway | R-ALL-9705578 | 0 | FAD | 145068 | smpdb |
| Hyperprolinemia Type II | R-HSA-2127377 | 0 | FAD | 145068 | smpdb |
| Wolman Disease | R-HSA-1643685 | 0 | FAD | 145068 | smpdb |
| Lysosomal Acid Lipase Deficiency | R-HSA-426024 | 0 | FAD | 145068 | smpdb |
| Trifunctional Protein Deficiency | R-HSA-77267 | 0 | FAD | 145068 | smpdb |
| Mitochondrial Complex II Deficiency | R-HSA-5602680 | 0 | FAD | 145068 | smpdb |
| 5-Oxoprolinase Deficiency | R-HSA-5602680 | 0 | FAD | 145068 | smpdb |
| Tyrosine Metabolism | R-HSA-8963691 | map00350 | FAD | 145068 | smpdb |
| Glutamate Metabolism | R-HSA-8964539 | 0 | FAD | 145068 | smpdb |